Literature DB >> 17618122

Synthesis, biological evaluation, and molecular modeling of 3,5-substituted-N1-phenyl-N4,N4-di-n-butylsulfanilamides as antikinetoplastid antimicrotubule agents.

Tesmol G George1, Molla M Endeshaw, Rachel E Morgan, Kiran V Mahasenan, Dawn A Delfín, Mitali S Mukherjee, Adam J Yakovich, Jean Fotie, Chenglong Li, Karl A Werbovetz.   

Abstract

Dinitroanilines are of interest as antiprotozoal lead compounds because of their selective activity against the tubulin of these organisms, but concern has been raised due to the potentially mutagenic nitro groups. Analogues of N(1)-phenyl-3,5-dinitro-N(4),N(4)-di-n-butylsulfanilamide (GB-II-150, compound 2b), a selective antimitotic agent against African trypanosomes and Leishmania, have been prepared where the nitro groups are replaced with amino, chloro, cyano, carboxylate, methyl ester, amide, and methyl ketone moieties. Dicyano compound 5 displays IC(50) values that are comparable to 2b against purified leishmanial tubulin assembly (6.6 vs 7.4 microM), Trypanosoma brucei brucei growth in vitro (0.26 vs 0.18 microM), Leishmania donovani axenic amastigote growth in vitro (4.4 vs 2.3 microM), and in vitro toxicity against Vero cells (16 vs 9.7 microM). Computational studies provide a rationale for the antiparasitic order of activity of these analogues and further insight into the role of the substituents at the 3 and 5 positions of the sulfanilamide ring.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17618122      PMCID: PMC1994923          DOI: 10.1016/j.bmc.2007.06.042

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  31 in total

1.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

2.  Leishmania tarentolae: purification and characterization of tubulin and its suitability for antileishmanial drug screening.

Authors:  Adam J Yakovich; Frank L Ragone; Juan D Alfonzo; Dan L Sackett; Karl A Werbovetz
Journal:  Exp Parasitol       Date:  2006-06-05       Impact factor: 2.011

3.  Binding and interaction of dinitroanilines with apicomplexan and kinetoplastid alpha-tubulin.

Authors:  Arpita Mitra; David Sept
Journal:  J Med Chem       Date:  2006-08-24       Impact factor: 7.446

4.  Inhibition of leishmanias but not host macrophages by the antitubulin herbicide trifluralin.

Authors:  M M Chan; D Fong
Journal:  Science       Date:  1990-08-24       Impact factor: 47.728

5.  Structure-function analysis of antimicrotubule dinitroanilines against promastigotes of the parasitic protozoan Leishmania mexicana.

Authors:  J D Berman
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

6.  Effect of the anti-microtubule drug oryzalin on growth and differentiation of the parasitic protozoan Leishmania mexicana.

Authors:  M M Chan; R E Triemer; D Fong
Journal:  Differentiation       Date:  1991-02       Impact factor: 3.880

7.  Antiprotozoal compounds from Psorothamnus polydenius.

Authors:  Manar M Salem; Karl A Werbovetz
Journal:  J Nat Prod       Date:  2005-01       Impact factor: 4.050

8.  Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.

Authors:  R Bai; Z A Cichacz; C L Herald; G R Pettit; E Hamel
Journal:  Mol Pharmacol       Date:  1993-10       Impact factor: 4.436

9.  Herbicides to curb human parasitic infections: in vitro and in vivo effects of trifluralin on the trypanosomatid protozoans.

Authors:  M M Chan; M Grogl; C C Chen; E J Bienen; D Fong
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

10.  Subpellicular microtubules associate with an intramembranous particle lattice in the protozoan parasite Toxoplasma gondii.

Authors:  N S Morrissette; J M Murray; D S Roos
Journal:  J Cell Sci       Date:  1997-01       Impact factor: 5.285

View more
  10 in total

Review 1.  Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis.

Authors:  Advait S Nagle; Shilpi Khare; Arun Babu Kumar; Frantisek Supek; Andriy Buchynskyy; Casey J N Mathison; Naveen Kumar Chennamaneni; Nagendar Pendem; Frederick S Buckner; Michael H Gelb; Valentina Molteni
Journal:  Chem Rev       Date:  2014-11-03       Impact factor: 60.622

2.  Synthesis and evaluation of oryzalin analogs against Toxoplasma gondii.

Authors:  Molla M Endeshaw; Catherine Li; Jessica de Leon; Ni Yao; Kirk Latibeaudiere; Kokku Premalatha; Naomi Morrissette; Karl A Werbovetz
Journal:  Bioorg Med Chem Lett       Date:  2010-07-08       Impact factor: 2.823

3.  Anticancer evaluation of a novel dithiocarbamate hybrid as the tubulin polymerization inhibitor.

Authors:  Jia Liu; Dongwei Xue; Xingwang Zhu; Liu Yu; Minghuan Mao; Yili Liu
Journal:  Invest New Drugs       Date:  2019-06-10       Impact factor: 3.850

4.  Microwave-assisted sequential one-pot protocol to benzothiadiazin-3-one-1,1-dioxides via a copper-catalyzed N-arylation strategy.

Authors:  Alan Rolfe; Paul R Hanson
Journal:  Tetrahedron Lett       Date:  2009-12-16       Impact factor: 2.415

5.  Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.

Authors:  Christopher Ma; Johnson Tran; Frank Gu; Roxanna Ochoa; Catherine Li; David Sept; Karl Werbovetz; Naomi Morrissette
Journal:  Antimicrob Agents Chemother       Date:  2010-02-09       Impact factor: 5.191

Review 6.  State of the art in African trypanosome drug discovery.

Authors:  Robert T Jacobs; Bakela Nare; Margaret A Phillips
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

7.  Novel drug design for Chagas disease via targeting Trypanosoma cruzi tubulin: Homology modeling and binding pocket prediction on Trypanosoma cruzi tubulin polymerization inhibition by naphthoquinone derivatives.

Authors:  Charles O Ogindo; Mozna H Khraiwesh; Matthew George; Yakini Brandy; Nailah Brandy; Ayele Gugssa; Mohammad Ashraf; Muneer Abbas; William M Southerland; Clarence M Lee; Oladapo Bakare; Yayin Fang
Journal:  Bioorg Med Chem       Date:  2016-06-16       Impact factor: 3.641

8.  Inhibitors of tubulin assembly identified through screening a compound library.

Authors:  Rachel E Morgan; Sunnoo Ahn; Sandra Nzimiro; Jean Fotie; Mitch A Phelps; Jeffrey Cotrill; Adam J Yakovich; Dan L Sackett; James T Dalton; Karl A Werbovetz
Journal:  Chem Biol Drug Des       Date:  2008-12       Impact factor: 2.817

9.  Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery.

Authors:  Sandra Duffy; Melissa L Sykes; Amy J Jones; Todd B Shelper; Moana Simpson; Rebecca Lang; Sally-Ann Poulsen; Brad E Sleebs; Vicky M Avery
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

10.  Preliminary Structure-Activity Relationship Study of the MMV Pathogen Box Compound MMV675968 (2,4-Diaminoquinazoline) Unveils Novel Inhibitors of Trypanosoma brucei brucei.

Authors:  Darline Dize; Rolland Bantar Tata; Rodrigue Keumoe; Rufin Marie Kouipou Toghueo; Mariscal Brice Tchatat; Cyrille Ngansop Njanpa; Vianey Claire Tchuenguia; Lauve Tchokouaha Yamthe; Patrick Valere Tsouh Fokou; Benoît Laleu; James Duffy; Ozlem Tastan Bishop; Fabrice Fekam Boyom
Journal:  Molecules       Date:  2022-10-04       Impact factor: 4.927

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.